Timing of PDA Closure and Respiratory Outcome in Premature Infants
NCT00802685 is an interventional trial sponsored by University of Miami. As of 21 Nov 2026, it was terminated. It studies Early ibuprofen in Patent Ductus Arteriosus. The registry lists an enrollment of 105 participants at 1 site in 1 country. The registry lists a start date of 30 Nov 2007 and a primary completion date of 31 Aug 2010.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT00802685 |
| Status | Terminated |
| Study type | Interventional trial |
| Lead sponsor | University of Miami |
| Enrollment | 105 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Patent Ductus Arteriosus |
| Drugs | Early ibuprofen |
| Start | 30 Nov 2007 |
| Primary completion | 31 Aug 2010 |
| Study completion | 28 Feb 2011 |
| Last update posted | 5 Feb 2014 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Ilene RS Sosenko, MD
University of Miami
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Jackson Memorial Hospital/holtz Children's Center
Miami
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT00802685
Each answer restates registry values shown on this page.
What is NCT00802685?
NCT00802685 is an interventional trial sponsored by University of Miami. It studies Early ibuprofen in Patent Ductus Arteriosus.
Who leads NCT00802685?
The registry names Ilene RS Sosenko, MD (principal investigator, University of Miami) as the overall official.
Where does NCT00802685 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
Which drugs does NCT00802685 study?
The registered drug and biological interventions are Early ibuprofen.
When did NCT00802685 end?
The registry lists a primary completion date of 31 Aug 2010 and a study completion date of 28 Feb 2011. The sponsor last updated the record on 5 Feb 2014.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.